ATTE: Long-term Anastrozole versus Tamoxifen Treatment Effects

Not Applicable

• Conditions: Breast cancer; Cancer; Malignant neoplasm of the breast

• Registration Number: ISRCTN86305500
• Lead Sponsor: Queen Mary University of London (UK)

Brief Summary

2017 Abstract results in http://cancerres.aacrjournals.org/content/77/4_Supplement/P2-09-03.short 100-month follow-up conference abstract (added 25/02/2019) 2010 Results article in https://www.ncbi.nlm.nih.gov/pubmed/21087898 10-year follow-up results (added 25/02/2019) 2003 Results article in https://www.ncbi.nlm.nih.gov/pubmed/14584060 results (added 25/02/2019) 2008 Results article in https://www.ncbi.nlm.nih.gov/pubmed/18083636 results (added 25/02/2019)

Detailed Description

Not available

Study Timeline

• Study Start: 2009-03-30
• Last Update Posted: 22 April 2024
• Study Completion: 2026-02-28

Recruitment & Eligibility

• Status: Ongoing
• Sex: Female
• Target Recruitment: 1342

Inclusion Criteria

1. Patients randomised to one of the monotherapy arms in the ATAC trial (randomised to the ATAC trial during the period 1996 - 2003 and were female, post-menopausal and 45 years and above at the time of randomisation)
2. Alive at 10 years follow-up

Exclusion Criteria

1. Patients who have withdrawn consent to participate in the ATAC trial or this study
2. Where the LATTE Executive Committee determines that there is no possibility of obtaining follow-up

Study & Design

• Study Type: Observational
• Study Design: Not specified